Lakefront Biotherapeutics · EURONEXT:LKFT

Tang Capital Management LLC reported a 8.40% stake in Lakefront Biotherapeutics (Schedule 13G)

Event Oct 27, 2025 · Filed Oct 29, 2025

Tang Capital Management LLC reported a 8.40% stake in Lakefront Biotherapeutics, 5,559,674 shares, as a passive investor on Oct 27, 2025. Filed Oct 29, 2025 (Schedule 13G).

Stake
8.40%
Shares
5,559,674
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
TANG CAPITAL MANAGEMENT, LLC8.40%5,559,674
KEVIN TANG8.40%5,559,674
TANG CAPITAL PARTNERS, LP5.00%3,313,189
TANG CAPITAL PARTNERS INTERNATIONAL, LP3.40%2,246,485
TANG CAPITAL PARTNERS III, INC0%0
TANG CAPITAL PARTNERS IV, INC0%0

Source

View original at SEC

Related